Augmentin Tablets is a medicine brand authorised in South Africa. This page provides limited product identification information only .
Medicine name : Augmentin Tablets
Country: South Africa
Schedule: S4
Active ingredients :
| Product / Form | Active Ingredient | Strength | Inactive Ingredient |
|---|---|---|---|
| AUGMENTIN BD film-coated tablet | Amoxicillin trihydrate | Equivalent to 875 mg amoxicillin | Colloidal anhydrous silica |
| AUGMENTIN BD film-coated tablet | Potassium clavulanate | Equivalent to 125 mg clavulanic acid | Magnesium stearate |
| — | — | — | Microcrystalline cellulose |
| — | — | — | Sodium starch glycollate |
| — | — | — | Titanium dioxide |
| — | — | — | Hydroxypropyl methylcellulose |
| — | — | — | Polyethylene glycol |
| — | — | — | Silicone oil |
| — | — | — | Sugar-free |
Augmentin Tablets is a scheduled medicine in South Africa. Detailed information, including its uses, warnings, precautions, dosage guidance and possible side effects, is intended only for registered healthcare professionals or for patients to whom the medicine has been legally prescribed.
This page does not provide medical advice, treatment recommendations, promotional claims, or instructions for use. Please consult a registered doctor, pharmacist, or other qualified healthcare professional for information specific to your condition and prescription.
For your safety, do not use Augmentin Tablets unless it has been prescribed or supplied to you in accordance with South African medicine regulations.
Manufacturer/holder
GlaxoSmithKline South Africa (Pty) Ltd
39 Hawkins Avenue
Epping Industria 1, 7460
SAHPRA / product identifier : AUGMENTIN BD tablets: 32/20.1.2/0239
AUGMENTIN SR tablets: 36/20.1.2/0288
Sources
Written by: RxZest Editorial Team
Editorial review: Checked for readability, structure, and source alignment
Based on SAHPRA-approved information : Augmentin Tablets
Last updated: [13/05/2026]
